New York State Common Retirement Fund grew its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 18.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 111,738 shares of the medical device company’s stock after buying an additional 17,668 shares during the quarter. New York State Common Retirement Fund’s holdings in Globus Medical were worth $5,548,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Geneos Wealth Management Inc. bought a new stake in shares of Globus Medical during the 2nd quarter valued at approximately $27,000. Quarry LP bought a new stake in shares of Globus Medical during the 1st quarter valued at approximately $27,000. Advisory Services Network LLC grew its holdings in shares of Globus Medical by 109.6% during the 1st quarter. Advisory Services Network LLC now owns 503 shares of the medical device company’s stock valued at $28,000 after purchasing an additional 263 shares during the last quarter. Altshuler Shaham Ltd bought a new stake in shares of Globus Medical during the 4th quarter valued at approximately $28,000. Finally, Harbor Investment Advisory LLC bought a new stake in shares of Globus Medical during the 3rd quarter valued at approximately $56,000. 80.54% of the stock is currently owned by institutional investors and hedge funds.
Globus Medical Trading Down 0.2 %
NYSE:GMED opened at $52.36 on Monday. The firm’s fifty day moving average is $52.41 and its 200-day moving average is $51.64. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.36 and a current ratio of 4.47. Globus Medical, Inc. has a 52 week low of $43.38 and a 52 week high of $62.88. The firm has a market cap of $7.21 billion, a P/E ratio of 33.78, a P/E/G ratio of 1.73 and a beta of 1.10.
Wall Street Analysts Forecast Growth
Globus Medical Company Profile
Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
- Five stocks we like better than Globus Medical
- What Are Utility Stocks? An Overview of the Utilities Sector
- MarketBeat Week in Review – 2/5 – 2/9
- How to Invest in Semiconductors
- Cloudflare results spark analysts reset: 25% upside ahead
- The Significance of Brokerage Rankings in Stock Selection
- Beyond Nvidia: The hidden stars with 200% earnings growth
Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter.